Related Experiment Video
Updated: Jun 16, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
The brothers RAF
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Abstract:
Targeted molecular therapies for cancer treatment have shown promise, but also have limitations. In this issue, Heidorn et al. (2010) find that a class of targeted molecular therapies with clinical effectiveness against one melanoma subtype may have adverse clinical effects in another.
Insights
Targeted molecular therapies show promise for cancer, but can have limitations. A study found that therapies effective against one melanoma subtype may harm another.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Targeted molecular therapies offer precision in cancer treatment.
- These therapies aim to inhibit specific molecules driving cancer growth.
- Melanoma, a skin cancer, comprises various subtypes with distinct molecular profiles.
Discussion:
- Heidorn et al. (2010) investigated the differential effects of targeted therapies across melanoma subtypes.
- The study identified a specific targeted therapy effective in one subtype.
- This therapy demonstrated adverse clinical effects in a different melanoma subtype.
Key Insights:
- Targeted therapies are not universally effective across all cancer subtypes.
- Molecularly distinct cancer subtypes can exhibit differential responses to the same drug.
- Clinical effectiveness in one subtype does not guarantee safety or efficacy in another.
Outlook:
- Further research is needed to understand subtype-specific mechanisms of drug response and resistance.
- Development of personalized treatment strategies tailored to individual melanoma subtypes is crucial.
- This highlights the complexity of targeted cancer therapy and the need for careful patient stratification.
More Related Videos
Related Concept Videos
Rab Cascades
The Ras Gene
Ras is a superfamily...
The Ras Gene
Ras is a superfamily...
Robbers Cave
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rabies

